COLLAGEN
Food supplement declared in France, declaration No 2022-11-1124, decision dated 23 November 2022
COLLAGEN (B7) is a food supplement declared in France. Status: declared in France, may be marketed. None of the rules we check flags an issue with its declared composition; vitamin and mineral doses are not published by Compl'Alim and are therefore not checked.
- Brand
- B7
- Food business operator placing the product on the market
- AYOLABS
- Status
- Declared in France, may be marketed: the authorities did not object to the declaration (this is neither an authorisation nor a safety assessment)
- Form
- Powder
- Daily dose
- 8 g
- Directions for use
- Prendre 8 g de produit et melanger avec 200-250 ml d´eau
- Intended populations
- Men, Women
- Objectives stated by the manufacturer (these are not authorised claims)
- Joints, Sport
- Flavourings
- LEMON
Declaration 239039, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 15 November 2026.
Declared composition
Plants
| Plant | Part | Preparation | Per day |
|---|---|---|---|
| Harpagophytum procumbens | Racine | Extrait sec hydroalcoolique | 300 mg |
| Boswellia serrata Roxb. ex Colebr. | Gomme résine | Extrait sec hydroalcoolique | 15 mg |
Other active ingredients
| Name | Per day |
|---|---|
| Collagène hydrolysé | not declared |
| Sulfate de glucosamine | not declared |
| Méthylsulfonate de méthane | not declared |
| Acide hyaluronique | not declared |
Vitamins and minerals
Compl'Alim does not publish vitamin and mineral doses. The references below help you read the product label: EFSAEuropean Food Safety Authority. safety limit for adults and maximum dose set in France per product (Order of 9 May 2006, not revised since November 2006).
| Declared form | Nutrient | EFSA limit, adults | Maximum dose in France |
|---|---|---|---|
| Carbonate de calcium | Calcium | 2,500 mg | 800 mg |
| Sels de magnésium de l'acide citrique | Magnésium | 250 mg | 300 mg |
| Acide L-ascorbique | Vitamine C | pas de limite (données insuffisantes) | 180 mg |
| Cholécalciférol | Vitamine D | 100 µg (4,000 UI) | 5 µg (200 UI) |
Additives
E330, E955, E950
Other ingredients
maltodextrine
List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).
Regulatory points
None of the rules we check applies to the declared ingredients.
This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
Official warnings (Health Canada)
Health Canada publishes warnings on these ingredients:
- Harpagophytum procumbens
Read the warning, when it applies and the studies cited
DEVIL'S CLAW - HARPAGOPHYTUM
Route of administration: Oral
Cautions and warnings
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding.
- Collagène hydrolysé
Read the warning, when it applies and the studies cited
Hydrolyzed Collagen
Route of administration: Oral
Cautions and warnings
Condition of application: Joint pain.
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms worsen.
Applies to products providing more than 2.8 g hydrolyzed collagen, per day.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding (Shils et al. 2006; Goldman and Ausiello 2004).
Sources cited by Health Canada (2)
- Goldman L, Ausiello D, editors. Cecil Textbook of Medicine, Volume 1, 22nd edition. Philadelphia (PA): Saunders; 2004.
- Shils ME, Shike M, Ross AC, Caballero B, Cousins RJ, editors. Modern Nutrition in Health and Disease, 10th edition. Philadelphia (PA): Lippincott Williams and Wilkins, 2006.
Known adverse reactions
When using this product you may experience gastrointestinal discomfort/disturbances (Moskowitz 2000).
Sources cited by Health Canada (1)
- Moskowitz RW. Role of collagen hydrolysate in bone and joint disease. Seminars in Arthritis and Rheumatism 2000;30(2):87-99. PubMed Randomised trial
- Méthylsulfonate de méthane
Read the warning, when it applies and the studies cited
MSM
Route of administration: Oral
Cautions and warnings
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms worsen.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding.
Known adverse reactions
When using this product you may experience gastrointestinal discomfort/disturbances (Kim et al. 2005).
1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).
They concern the ingredient, not this product or its dose. They do not replace medical advice.
Other declarations with the same name
This name is used by more than 10 declarations from different companies, so it does not identify one product. See every declaration with this name.
Brand : B7
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.